| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 35.43× | 35.43× | 40.87× | 44.41× | 39.00× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.63× | 1.58× | 1.41× | 1.31× | 1.33× | ||
| 0.46× | 0.46× | 0.52× | 0.52× | 0.51× | ||
| 0.59× | 0.59× | 1.14× | 0.86× | 0.85× | ||
| 0.38× | 0.38× | 0.82× | 0.58× | 0.57× |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 39.00 | 44.41 | 40.87 | 35.43 | 35.43 | |
| Working Capital Turnover | 1.33 | 1.31 | 1.41 | 1.58 | 1.63 | |
| Asset Turnover | 0.51 | 0.52 | 0.52 | 0.46 | 0.46 | |
| Cash Conversion (CFO/Net Income) | 0.85 | 0.86 | 1.14 | 0.59 | 0.59 | |
| CFO/EBITDA | 0.57 | 0.58 | 0.82 | 0.38 | 0.38 |